1336P Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy

• DOI: 10.1016/j.annonc.2023.09.2369
• Publication Date: 2023-10-20T13:00:08Z
• Authors: F.C. Saalfeld; J. Möller; S. Michels; C. Grohe; M. Wiesweg; C. Schubart; J. Alt; F. Griesinger; D. Kauffmann-Guer...; J. Kulhavy; T.R. Overbeck; N. Pelusi; G. Rohde; C. Wesseler; I. Vathiotis; R. Veluswamy; O.M. Illini; S.I. Rothschild; P. Christopoulos; M. Wermke
• Keywords: Progression-free survival